International Research Journal of Diabetes and Metabolism


Emerging Nephrotic Problems among Diabetic Patients of Bangladesh

Review Article of International Research Journal of Diabetes and Metabolism Emerging Nephrotic Problems among Diabetic Patients of Bangladesh AK MOHIUDDIN Faculty of Pharmacy, World University of Bangladesh Nearly 80% of people with diabetes live in low- and middle-income countries. It increases healthcare expenditure and imposes a huge economic burden on the healthcare systems. The International Diabetes Federation estimated more than 7 million people with diabetes in Bangladesh and almost an equal number with unexplored diabetes. This number is estimated to double by 2025. It is a costly condition and may cause stroke, heart attack, chronic kidney diseases, neuropathy, visual impairment and amputations. Bangladesh is a developing country where 75% of total population lives in rural area. Subsequently they have poor healthcare access as 26% of rural professionals remain vacant and nearly 40%, absent. Nearly 45% rural people take medical assessment from unqualified health workers including medical assistants, mid-wives, village doctors, community health workers in comparison to that by qualified medical graduates (only 10%-20%). More than 75% women having complications taken treatment from an unqualified provider. These are mostly because concern over medical costs, and pronounced socioeconomic disparities found for care-seeking behavior in both urban and rural Bangladesh. Keywords:  Diabetic Patient; Glycemic Control; kidney Function; Stroke; Blood Sugar; Albuminuria ...

Diabetes Fact: Bangladesh Perspective

Review Article of International Research Journal of Diabetes and Metabolism Diabetes Fact: Bangladesh Perspective AK MOHIUDDIN Faculty of Pharmacy, World University of Bangladesh Bangladesh is a developing country where 75% of total population lives in rural area. Subsequently they have poor healthcare access as 26% of rural professionals remain vacant and nearly 40%, absent. Although official documents indicate that 80% of the population has access to affordable essential drugs, there is plenty of evidence of a scarcity of essential drugs in government healthcare facilities. Nearly 45% rural people take medical assessment from unqualified health workers including medical assistants, mid-wives, village doctors, community health workers in comparison to that by qualified medical graduates (only 10%-20%). More than 75% women having complications sought treatment from an unqualified provider. These are mostly because concern over medical costs, and pronounced socioeconomic disparities found for care-seeking behavior in both urban and rural Bangladesh. However, the government’s expenditure on health is the third largest in the country, after education and defense. Diabetes is a complicated chronic disease; non-compliant patients are in a risk of moderate to severe complications, to much extent unexplored to maximum people of Bangladesh. Annually diabetes is responsible for 5% of all deaths globally, and its prevalence is increasing steadily. As reported by International Diabetes Federation (IDF), approximately 75–80% of people with diabetes die due to cardiovascular complications. Keywords:  Bangladesh; Diabetes; Prevalence; Glycemic Control; Obesity; Stroke ...

To characterize the sociodemographic, clinical, therapeutic and quality of life of users of the Unified Health System with Diabetes mellitus

Research Article of International Research Journal of Diabetes and Metabolism To characterize the sociodemographic, clinical, therapeutic and quality of life of users of the Unified Health System with Diabetes mellitus Silva L.L.S.B.¹; Gonzaga I.A.A.S.²; Santos E.K.M.³; Silva L.N.M.4; Santos E.C.B.5 ¹Acadêmica do Curso de Graduação em Enfermagem da Universidade Federal de Pernambuco. Brasil; 2 ,3Enfermeiras pela Universidade Federal de Pernambuco. Brasil. 4Acadêmica do Curso de Graduação em Enfermagem da Universidade Federal de Pernambuco, 5Doutora em Enfermagem pela USP. Professora Adjunta da Universidade Federal de Pernambuco. Brasil. Orientadora. Introduction: Descriptive study with a quantitative approach carried out between October 2015 and October 2016. Sampling was about 100 people with diabetes. Objective: To characterize the sociodemographic, clinical, therapeutic and quality of life of users of the Unified Health System with Diabetes mellitus in a Basic Health Unit (BHU) of the Rural Zone of the city of Vitória de Santo Antão. Methods: Two questionnaires, sociodemographic, clinical and therapeutic, and DQUOL-BRASIL, both validated, were used. Results and discussion: Higher prevalence of female people (75%). Of the investigators (51%) were not able to report their type of diabetes, the medication was obtained in the BHU (44%) as well as the follow-up (78%). (44%) did not receive the blood glucose strips, and (92%) did not participate in educational programs. Regarding the quality of life or impact domain, the highest mean was obtained (32.05) and the lowest for the sale of diabetes problems (6.66). Conclusion: It is concluded that the results obtained contribute to increase the knowledge about the factors studied, since knowing a population makes possible the development of effective health actions, considering the local specificities. Keywords:   Diabetes Mellitus, Health Profile, Quality of Life, Rural Areas ...

Effects of oral antidiabetics on cancer incidence and mortality

Research Article of International Research Journal of Diabetes and Metabolism Effects of oral antidiabetics on cancer incidence and mortality Neto, P. P. M 1; Silva, M. R. P 2; Soares, C. L. R 3; Lucena, C. C. O 4; Pereira, P. S 5; Silva, T. G6 1Postgraduate Program of Biological Sciences, Federal University of Pernambuco - UFPE, 2 Undergraduate student of Biological Sciences, Federal University of Pernambuco – UFPE; 3Postgraduate Program of Pharmaceutical Sciences, Federal University of Pernambuco - UFPE; 4 Postgraduate Program of Northeast Biotechnology Network - RENORBIO, Federal University of Pernambuco - UFPE; 6 Professor/Researcher on Department of Antibiotics, Federal University of Pernambuco - UFPE. Introduction: Type 2 diabetes mellitus is a chronic progressive disease that can be controlled by any oral hypoglycemic, with biguanides, thiazolidinediones and sulfonylureas being the main classes of these drugs in the pharmaceutical market. Epidemiological analyzes suggest that diabetics are at higher risk of developing tumors than normoglycemics. A large number of studies have shown the link between oral antidiabetic drugs and developmental rates and mortality in cancer cases. Objective: To present clinical and preclinical results on the relationship between oral hypoglycemic agents and cancer. Methodology: A bibliographical survey was carried out of the main academic journals, with prevalence of articles from the last five years. Results and Discussion: Metformin is a biguanide that phosphorylates hepatic cyclic AMP, a mechanism also proposed as antineoplastic. Epidemiological studies associate the use of metformin with the lower incidence of hepatocellular and pancreatic cancers in diabetic patients. Other studies have shown a 21% lower mortality rate in women with breast cancer and 24% lower in men with prostate cancer who took metformin. Thiazolidinediones are receptor agonists, predominantly present in adipocytes, capable of increasing glucose uptake and improving insulin sensitivity. Randomized trials have shown that pioglitazone was associated ...

Manuscript Title: The title should be a brief phrase.

Author Information: List full names and affiliation of all authors, including Emails and phone numbers of corresponding author.

Abstract: The abstract should be less than 500 words. Following abstract, a list of keywords and abbreviations should be added. The keywords should be no more than 10. Abbreviation are only used for non standard and long terms.

Introduction: The introduction should included a clear statement of current problems.

Materials and Methods: This section should be clearly described.

Results and discussion: Authors may put results and discussion into a single section or show them separately.

Acknowledgement: This section includes a brief acknowledgment of people, grant details, funds

References: References should be listed in a numbered citation order at the end of the manuscript. DOIs and links to referenced articles should be added if available. Abstracts and talks for conferences or papers not yet accepted should not be cited. Examples Published Papers: 

1. Avinaba Mukherjee, Sourav Sikdar, Anisur Rahman Khuda-Bukhsh. Evaluation of ameliorative potential of isolated flavonol fractions from Thuja occidentalis in lung cancer cells and in Benzo(a) pyrene induced lung toxicity in mice. International Journal of Traditional and Complementary Medicine, 2016; 1(1): 0001-0013. 
2. Vikas Gupta, Parveen Bansal, Junaid Niazi, Kamlesh Kohli, Pankaj Ghaiye. Anti-anxiety Activity of Citrus paradisi var. duncan Extracts in Swiss Albino Mice-A Preclinical Study. Journal of Herbal Medicine Research, 2016; 1(1): 0001-0006.

Tables and figures: Tables should be used at a minimum with a short descriptive title. The preferred file formats for Figures/Graphics are GIF, TIFF, JPEG or PowerPoint.

Proofreading and Publication: A proof will be sent to the corresponding author before publication. Authors should carefully read the proof to avoid any errors and return the proof to the editorial office. Editorial office will publish the article shortly and send a notice to authors with the links of the paper.

Open Access

International Research Journal of Diabetes and Metabolism (ISSN:2637-6717;10.28933/IRJDM) is a peer reviewed open access journal publishing research manuscripts, review articles, editorials, letters to the editor in Diabetes and Metabolism.

Peer Review

To ensure the quality of the publications, all submitted manuscripts will be peer-reviewed by invited experts in the field. The decisions of editors will be made based on the comments of the reviewers.

Rapid Publication

Time to first decision: within 2 days for initial decision without review, 18 days with review; Time to publication: Accepted articles will be published online within 2 days, and final corrected versions by authors will be accessible within 5 days.  More details....

Rapid Response Team

Please feel free to contact our rapid response team if you have any questions. Our customer representative will answer your questions soon.

International Research Journal of Diabetes and Metabolism

Upload

Note: Please compress all documents (manuscript, cover letter et al.,.) into one .Zip file and then upload the Zip file.